申请人:Imperial Chemical Industries PLC
公开号:US05286740A1
公开(公告)日:1994-02-15
The present invention concerns novel carbamoyl derivatives of formula I, set out herein, which antagonize the pharmacological actions of one or more of the arachidonic acid metabolites known as leukotrienes, making them useful whenever such antagonism is desired, such as in the treatment of those diseases in which leukotrienes are implicated, for example, in the treatment of allergic or inflammatory diseases, or of endotoxic or traumatic shock conditions. The invention also provides pharmaceutical compositions containing the novel derivatives for use in such treatments, methods for their use and processes and intermediates for the manufacture of the novel derivatives.
本发明涉及一种新的氨基甲酰衍生物,其化学式为I,该衍生物在此处列出,能拮抗被称为白三烯的花生四烯酸代谢产物的药理作用,使其在需要拮抗这种作用的情况下非常有用,例如在白三烯参与的疾病治疗中,例如在过敏性或炎症性疾病的治疗中,或在内毒素性或创伤性休克症状的治疗中。该发明还提供了含有这些新衍生物的药物组合物,用于进行这种治疗的方法,以及用于制造这些新衍生物的方法和中间体。